{"id":"NCT05157841","sponsor":"Pacira Pharmaceuticals, Inc","briefTitle":"Phase 3, Sciatic Nerve Block With EXPAREL for Subjects Undergoing Bunionectomy","officialTitle":"A Phase 3, Randomized, Double-Blind, Active-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL vs. Bupivacaine Hydrochloric Acid (HCl) Administered as a Sciatic (in the Popliteal Fossa) Nerve Block for Postsurgical Analgesia in Subjects Undergoing Bunionectomy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-02-15","primaryCompletion":"2022-08-17","completion":"2022-08-17","firstPosted":"2021-12-15","resultsPosted":"2025-06-26","lastUpdate":"2025-06-26"},"enrollment":185,"design":{"allocation":"RANDOMIZED","model":"SEQUENTIAL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Bunionectomy","Hallux Valgus"],"interventions":[{"type":"DRUG","name":"Bupivacaine liposome injectable suspension 266 mg","otherNames":["EXPAREL"]},{"type":"DRUG","name":"Bupivacaine HCl","otherNames":[]},{"type":"DRUG","name":"Bupivacaine liposome injectable suspension 133 mg","otherNames":["EXPAREL"]}],"arms":[{"label":"Part A: EXPAREL 266 mg arm","type":"EXPERIMENTAL"},{"label":"Part A: EXPAREL 133 mg arm","type":"EXPERIMENTAL"},{"label":"Part A: Bupivacaine HCl arm","type":"ACTIVE_COMPARATOR"},{"label":"Part B: EXPAREL 133 mg arm OR EXPAREL 266 mg arm","type":"EXPERIMENTAL"},{"label":"Part B: Bupivacaine HCl arm","type":"ACTIVE_COMPARATOR"}],"summary":"The study is conducted sequentially in two parts.\n\nPart A: The purpose is to obtain information on pharmacokinetic (PK) profile, pharmacodynamics (PD), efficacy, safety, and to assess the performance of 266 mg EXPAREL vs 133 mg EXPAREL.\n\nPart B: The purpose is to evaluate the efficacy and safety of the preferred dosage of EXPAREL from Part A compared with bupivacaine HCl.","primaryOutcome":{"measure":"NRS Pain Scores Through 96 Hours Post-surgery","timeFrame":"0- 96 hours post-surgery","effectByArm":[{"arm":"Part A: EXPAREL 266 mg Arm","deltaMin":342.3,"sd":265.35},{"arm":"Part A + B: EXPAREL 133 mg Arm","deltaMin":201.3,"sd":180.05},{"arm":"Part A + B: Bupivacaine HCl Arm","deltaMin":377.4,"sd":188.6}],"pValues":[{"comp":"OG001 vs OG002","p":"<0.00001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":7,"countries":["United States"]},"refs":{"pmids":["38340677"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":22},"commonTop":["Nausea","Constipation","Vomiting","Headache","Pruritus"]}}